Glaxo Agrees To $3.4B Settlement
Pharmaceutical giant GlaxoSmithKline has agreed shell out more than $3 billion to settle a dispute with the U.S. Internal Revenue Service and avoid a courtroom showdown with the IRS that had...To view the full article, register now.
Already a subscriber? Click here to view full article